Skip to main content
TipRanks
Go Ultimate75% OFF

M1 Kliniken AG (M12) AI Stock Analysis

14 Followers
DE:M12

M1 Kliniken AG

(XETRA:M12)

Select Model
Rating:73Outperform
Price Target:EUR 22.50▲(15.38% Upside)
Action:reiterated
Date:10/10/26

M1 Kliniken earns an above-average score driven primarily by solid fundamentals: rapid revenue growth, expanding profitability, a very low debt-to-equity ratio of 0.10, 15% ROE and strong free cash flow that fully backs reported earnings. Valuation adds support, with a moderate 18.2x P/E and a high 5.97% dividend yield. Technicals are constructive, with the stock above its 50-, 100- and 200-day averages, though near-term momentum has flattened into consolidation. Key risks are the projected gross margin compression for 2025, still-modest net margins versus larger healthcare peers, and the prior volatility in cash flow seen in 2023.

Positive Factors
Conservative balance sheetVery low leverage reduces financing pressure and preserves flexibility for clinic expansion, investment, or shareholder returns. Growing equity provides an additional buffer against operating volatility, while modest debt limits the drag from interest costs over the next several quarters.
Negative Factors
Revenue growth is slowingThe continued deceleration in annual revenue growth indicates that expansion and demand momentum are moderating. If this pattern persists, slower top-line progression could limit operating leverage, reduce the pace of earnings growth, and make future performance more dependent on margin improvement.

M1 Kliniken AG (M12) vs. iShares MSCI Germany ETF (EWG)

-20%-10%0%10%20%30%40%50%DE:M12+28.91%EWG+4.05%Dec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26Nov '26
Market Cap
EUR 361.82M
Dividend Yield
6.15%
Average Volume (3M)
4,251
Price to Earnings (P/E)
17.9
Beta (1Y)
0.32
Revenue Growth
-27.50%
EPS Growth
13.64%
Country
Germany
Employees
280
Sector
Healthcare
Sector Strength
51
Industry
Medical - Care Facilities

M1 Kliniken AG Business Overview & Revenue Model

Company Description

M1 Kliniken AG, a Berlin, Germany-based entity established in 2007 and operating as a subsidiary of MPH Health Care AG, manages medical facilities dedicated to aesthetic and plastic surgery across Germany, Austria, the Netherlands, Switzerland, the U...

How the Company Makes Money

M1 Kliniken AG generates revenue mainly from two business areas. (1) Aesthetics/clinic operations: The company earns money by providing aesthetic medical treatments directly to patients in its clinic network. Revenue is recognized from patient-paid p...

M1 Kliniken AG Financial Statement Overview

Summary

Blending the Income Statement (72), Balance Sheet (78) and Cash Flow (76) scores, M1 Kliniken shows a strong growth and deleveraging profile. Revenue has more than doubled since 2020 to an estimated €364M in 2025, net income rose from €4.3M (2022) to €16M (2024) with €22.1M projected for 2025, and margins have expanded (net margin 1.5% to 4.7%). The balance sheet is conservative, with debt cut to €10.3M, a debt-to-equity ratio of 0.10, equity near 63% of assets and ROE improving to 15.1%. Cash generation is robust, with operating cash flow of €30.5M in 2024 and free cash flow closely tracking net income, confirming earnings quality. Offsetting factors include still-moderate net margins for the healthcare sector, apparent gross profit compression in the 2025 projection despite higher revenue, and the one-off cash flow dip in 2023.

Income Statement

72Positive

Balance Sheet

78Positive

Cash Flow

76Positive
Financial statement breakdown
BreakdownTTMDec 2025Mar 2025Dec 2023Dec 2022Dec 2021
Income Statement
Total Revenue257.36M364.30M339.18M316.32M285.29M314.61M
Gross Profit47.67M47.43M63.60M32.47M21.72M26.06M
EBITDA36.64M40.49M33.38M21.79M16.07M19.78M
Net Income20.23M22.13M16.02M10.27M4.32M8.91M
Balance Sheet
Total Assets177.40M189.29M187.87M212.95M197.02M198.11M
Cash, Cash Equivalents and Short-Term Investments60.50M42.00M23.69M22.76M47.50M49.12M
Total Debt5.90M10.26M10.42M17.04M19.67M30.93M
Total Liabilities25.14M39.28M53.65M69.73M53.97M58.21M
Stockholders Equity124.18M119.93M106.10M113.25M95.52M95.03M
Cash Flow
Free Cash Flow23.08M37.84M29.55M6.80M19.25M14.32M
Operating Cash Flow23.29M37.95M30.55M7.81M21.02M15.66M
Investing Cash Flow22.41M-645.81K-5.67M-9.36M-1.77M213.19K
Financing Cash Flow-13.07M-13.41M-30.44M-14.81M-21.97M4.03M

M1 Kliniken AG Technical Analysis

Technical Analysis SentimentPositive
Last Price19.50

Price Trends

50DMA19.83Negative
100DMA19.21Positive
200DMA17.47Positive

Market Momentum

MACD-0.08Negative
RSI50.29Neutral
STOCH57.66Neutral

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For DE:M12, the sentiment is Positive. The current price of 19.50 is above the 20-day moving average (MA) of 19.36, below the 50-day MA of 19.83, and above the 200-day MA of 17.47, indicating a neutral trend. The MACD of -0.08 indicates Negative momentum. The RSI at 50.29 is Neutral, neither overbought nor oversold. The STOCH value of 57.66 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for DE:M12.

M1 Kliniken AG Peers Comparison

Overall Rating

UnderperformOutperform
Sector (51)

Financial Indicators

DE:M12 against its peers
NameOverall RatingMarket CapP/E RatioROEDividend YieldRevenue GrowthEPS Growth
DE:M12DE:M1273OutperformEUR 343.00M17.8916.58%6.15%-27.50%13.64%
DE:LIKDE:LIK67NeutralEUR 177.00M31.9322.18%1.69%35.46%17.88%
DE:FREDE:FRE63NeutralEUR 28.87B18.497.83%2.03%6.52%35.52%
DE:MEDDE:MED62NeutralEUR 249.38M7.9811.94%0.76%0.77%-11.41%
DE:RHKDE:RHK61NeutralEUR 970.61M22.663.16%1.38%3.54%11.21%
Sector *51Neutral$7.86B-0.30-43.30%2.27%22.53%-2.21%
DE:MAKDE:MAK27UnderperformEUR 17.51M-1.2816.80%―2.73%-1.80%

* Healthcare Sector Average

Performance Comparison

0%100%200%300%DE:M12DE:FREDE:MEDDE:RHKDE:MAKDE:LIKDec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26Nov '26
DE:M12 and its peers over the selected period
Show on chartTickerCompany NamePriceChange% Change
DE:M12M1 Kliniken AG19.504.6331.18%
DE:FREFresenius SE & Co. KGaA51.786.1113.38%
DE:MEDMEDICLIN AG5.251.8956.06%
DE:RHKRHON-KLINIKUM AG14.502.5020.79%
DE:MAKMATERNUS-Kliniken AG0.83-0.22-20.48%
DE:LIKLimes Schlosskliniken AG590.00248.6372.83%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.

Date of analysis: Oct 10, 2026